BERYL DRUGS Fact Sheet, BERYL DRUGS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BERYL DRUGS Fact Sheet    (BLDG)


Check Out: Why Millions of Dollars are Getting Pumped into this Sector?


Here is the latest financial fact sheet of BERYL DRUGS. For more details, see the BERYL DRUGS quarterly results and BERYL DRUGS share price and chart. For a sector overview, read our pharmaceuticals sector report.

BERYL DRUGS Price History

Price Rs 10.7
Mkt Cap Rs m 54
Vol '000 0.9
P/E X -40.5
P/CF X 7.7
EPS (TTM) Rs -0.3
% ch % 0.0
No. of shares m 5.07
% ch week % 1.9
% ch 1-mth % -13.1
% ch 12-mth % 69.7
52 week H/L Rs 19.3/5.2
(As on Dec 2, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BERYL DRUGS Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
BERYL DRUGS EQUITY SHARE DATA
High Rs534217189 
Low Rs2412964 
Sales per share (Unadj.) Rs25.121.129.725.625.3 
Earnings per share (Unadj.) Rs0.30.22.01.20.1 
Diluted earnings per shareRs0.30.22.01.20.1 
Cash flow per share (Unadj.) Rs1.11.02.61.81.4 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs13.113.413.114.815.0 
Adj. book value per shareRs13.113.413.114.815.0 
Shares outstanding (eoy) m5.075.075.075.075.07 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x1.51.30.40.50.2 
Avg P/E ratio x117.6118.16.710.064.9 
P/CF ratio (eoy) x33.927.85.06.44.4 
Price / Book Value ratio x2.92.01.00.80.4 
Dividend payout %00000 
Avg Mkt Cap Rs m196138665931 
No. of employees `000NANANANANA 
Total wages/salary Rs m1198810 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
BERYL DRUGS INCOME DATA
Net Sales Rs m127107150130128 
Other income Rs m43722 
Total revenues Rs m131110157132130 
Gross profit Rs m5510109 
Depreciation Rs m44337 
Interest Rs m22113 
Profit before tax Rs m221382 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m11321 
Profit after tax Rs m211060 
Gross profit margin %3.94.66.97.97.1 
Effective tax rate %32.131.522.025.869.6 
Net profit margin %1.31.16.64.60.4 
BERYL DRUGS BALANCE SHEET DATA
Current assets Rs m6073705475 
Current liabilities Rs m3342395566 
Net working cap to sales %21.328.920.5-1.06.9 
Current ratio x1.81.71.81.01.1 
Inventory Days Days4350413330 
Debtors Days Days1011221179798 
Net fixed assets Rs m3937389194 
Share capital Rs m5151515151 
"Free" reserves Rs m1617162425 
Net worth Rs m6768677576 
Long term debt Rs m0111323 
Total assets Rs m99111108145169 
Interest coverage x2.11.810.76.51.5 
Debt to equity ratio x0000.20.3 
Sales to assets ratio x1.31.01.40.90.8 
Return on assets %3.82.910.45.12.2 
Return on equity %2.51.714.97.80.6 
Return on capital %6.95.520.910.74.8 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
BERYL DRUGS CASH FLOW
From Operations Rs m -1 3 -1 33 2 
From Investments Rs m 2 1 0 -50 -16 
From Financial Activity Rs m -2 -2 -4 16 17 
Net Cashflow Rs m -2 1 -5 0 3 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 24.9%
Institution 0.0%
Non-Institution 75.1%
Total 100.0%
Free Float 75.1%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF 133, Kanchan Bagh, Indore - 452001
E-MAIL beryldrugs25@yahoo.com WEB
TEL 07292- 5065375 FAX 07292- 503295
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Adroit Corporate Services Pvt Ltd, 17-20 Jaferbhoy Industrial Estate 1st Floor, Makwana Road, Marol Naka
YEAR OF INC: 1993 BSE CODE: 524606 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   ROOPA INDUSTRIES  NUTRAPLUS PR  ISHITA DRUGS  STRIDES PHARMA SCIENCE  NORRIS MEDICINES  

Compare BERYL DRUGS With:   ROOPA INDUSTRIES  NUTRAPLUS PR  ISHITA DRUGS  STRIDES PHARMA SCIENCE  NORRIS MEDICINES  




Today's Market

Sensex Zooms 777 Points, Nifty Ends Above 17,400; Power & IT Stocks Rally(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BERYL DRUGS

  • Track your investment in BERYL DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON BERYL DRUGS

BERYL DRUGS - CIPLA COMPARISON

COMPARE BERYL DRUGS WITH

MARKET STATS